It is recommended that laboratories offering prenatal WES report pathogenic and likely pathogenic variants, as determined using ACMG variant interpretation guidelines in known disease genes consistent with the reported fetal phenotype [11, 12]. Through DNA and RNA validation, we proved that both variants affected splicing and might lead to frameshift of KIAA0586 gene. Therefore, the compound heterozygous mutations were rated as likely pathogenic combined with low frequency in general population. It is worth noting that the synonymous variant, at the last basepair of exon 23, can be easily neglected while analysis. However, the substitution leads to use of a cryptic splice site in exon 23 and deletion of 56 basepairs, resulting frameshift and in premature truncation of the KIAA0586 protein [13]. Therefore, disease databases such as ClinVar or HGMD and functional researches should be queried for putative pathogenic variants [13–15]. Moreover, impact of splice-site variants was confirmed through functional analysis by RNA in our study. RNA verification using the parents’ blood samples successfully prevented another invasive operation for the fetus and acquired rapid validation results for the family.
Recently, WES may be considered for a fetus with ultrasound anomalies after standard CMA and karyotype analysis have failed to yield a definitive diagnosis [16]. However, abnormal karyotype and CNVs can merely explain partially the genetic etiology, more than half of fetuses with sonographically identified structural anomalies remain without a diagnosis. In addition, WES is increasingly used in both pediatric and adult population, for multiple congenital anomalies, skeletal, neurodevelopmental and neuromuscular disorders [17–20]. Given the success in these patients, WES, limited to the analysis of coding regions of known genes, is currently applied prenatally. Studies reveal that WES increases the diagnostic yield in structurally abnormal fetuses by about 8–10% after normal karyotype and CMA results, and the detection rate is strongly proportional to the severity of phenotype [21, 22]. For our case, multiple fetal anomalies demonstrated a strong indication to implement prenatal WES. Instead of sequential testing, CMA and WES were simultaneously suggested and performed due to late gestation age, leading to a timely and comprehensive genetic diagnosis for the fetus.
Given the analysis of WES is phenotype driven; prenatal reporting of variants is of great challenge due to limited and ambiguous fetal imaging findings. Accurate identification of fetal structural anomalies is sophisticated by gestation age, fetal position, the ultrasound equipment, and the experience of clinicians [16]. The diagnostic yield rate of WES is strongly correlated with numbers of fetal anomalies and specificity of phenotypes [23]. Moreover, adequate clinical information, including reproductive history, family history and parental consanguinity, should be required to generate the most accurate interpretation of genetic results. Through routine scheme of antenatal care, fetal cerebral MRI would not have been arranged. Hence, MTS, the typical manifestation of JS, might have been undiscovered for the fetus. At 24 + weeks of gestation, the fetal femur length was merely one week shorter compared to fetuses of similar gestational age. Thanks to more intensive monitoring, fetal humerus length was found markedly shorter (-2.9SD), as well as small thoracic cage and cerebellar vermis revealed at 33 weeks of gestation by diagnostic ultrasound.
Due to genetic diagnosis during pregnancy, more tailored and frequent prenatal care (e.g. sonography and MRI) was implemented for the fetus. Consequently, the health-care professionals from multidisciplinary provided collectively clinical and genetic results for the couple. The genetic results can not only assist in determining the fetal prognosis, but also indicate the recurrence risk. According to authoritative databases such as OMIM, patients with KIAA0586 mutations might manifest JS or SRTD (type 14). Moreover, neurodevelopmental disorders, not detectable with fetal imaging, may onset after birth. The couple’s offspring has a likelihood of 25% to possess a compound heterozygous genotype, leading to diseases. Subsequently, informed genetic counseling about future reproductive options, including preimplantation genetic testing or diagnostic prenatal testing, could be addressed.